Home

Put husband Every week psa 0.04 his equator Hobart

When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK
When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK

Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC
Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC

Distribution of percent free PSA by total PSA for different age groups | Download Table
Distribution of percent free PSA by total PSA for different age groups | Download Table

Ethnicity Is an Independent Determinant of Age-Specific PSA Level: Findings from a Multiethnic Asian Setting | PLOS ONE
Ethnicity Is an Independent Determinant of Age-Specific PSA Level: Findings from a Multiethnic Asian Setting | PLOS ONE

Day 2,212 – PSA Results | Dan's Journey through Prostate Cancer
Day 2,212 – PSA Results | Dan's Journey through Prostate Cancer

KoreaMed Synapse
KoreaMed Synapse

Month 127 – PSA Results | Dan's Journey through Prostate Cancer
Month 127 – PSA Results | Dan's Journey through Prostate Cancer

Cancers | Free Full-Text | Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
Cancers | Free Full-Text | Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis

PDF) The effect of seminal vesicle-sparing radical prostatectomy on serum prostate-specific antigen level | caroline maake - Academia.edu
PDF) The effect of seminal vesicle-sparing radical prostatectomy on serum prostate-specific antigen level | caroline maake - Academia.edu

ESMO 2022: Association between prostate-specific antigen decline and clinical outcomes in patients with metastatic castration-resistant prostate cancer in the VISION trial
ESMO 2022: Association between prostate-specific antigen decline and clinical outcomes in patients with metastatic castration-resistant prostate cancer in the VISION trial

Month 134 – PSA Results | Dan's Journey through Prostate Cancer
Month 134 – PSA Results | Dan's Journey through Prostate Cancer

Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology

Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy | PLOS ONE
Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy | PLOS ONE

xmlinkhub
xmlinkhub

Day 2,701 — PSA Test Time - Cancer Health
Day 2,701 — PSA Test Time - Cancer Health

KoreaMed Synapse
KoreaMed Synapse

Cureus | Association of Nadir Prostate-specific Antigen >0.5 ng/mL after Dose-escalated External Beam Radiation with Prostate Cancer-specific Endpoints | Article
Cureus | Association of Nadir Prostate-specific Antigen >0.5 ng/mL after Dose-escalated External Beam Radiation with Prostate Cancer-specific Endpoints | Article

Detection of prostate specific antigen (PSA) in human saliva using an ultra-sensitive nanocomposite of graphene nanoplatelets with diblock-co-polymers and Au electrodes - Analyst (RSC Publishing)
Detection of prostate specific antigen (PSA) in human saliva using an ultra-sensitive nanocomposite of graphene nanoplatelets with diblock-co-polymers and Au electrodes - Analyst (RSC Publishing)